Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > We should trust someone who took the company from 1.50 to

<< Previous

Bullboard Posts

Next >>

Post by SamV21on Sep 29, 2021 11:43am

228 Views

Post# 33936974

We should trust someone who took the company from 1.50 to

.135 this year , he has no sense of FDA time, Phase 2 not finished could take a year, Phase 3 could take years, Phase 4 could take years ,THEN THEY CAN APPLY FOR DIN not before .He is buying himself a job...company will never go above .40 until the warrants expire in July 12,2022 .

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market